Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival.

Watanabe H, Ariyoshi Y, Pomposelli T, Takeuchi K, Ekanayake-Alper DK, Boyd LK, Arn SJ, Sahara H, Shimizu A, Ayares D, Lorber MI, Sykes M, Sachs DH, Yamada K.

Xenotransplantation. 2019 Sep 23:e12552. doi: 10.1111/xen.12552. [Epub ahead of print]

PMID:
31544995
2.

Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages.

Nomura S, Ariyoshi Y, Watanabe H, Pomposelli T, Takeuchi K, Garcia G, Tasaki M, Ayares D, Sykes M, Sachs D, Johnson R, Yamada K.

Xenotransplantation. 2019 Sep 8:e12549. doi: 10.1111/xen.12549. [Epub ahead of print]

PMID:
31495971
3.

Orbital Emphysema as a Consequence of Forceful Nose-Blowing: Report of a Case.

Ariyoshi Y, Naito H, Yumoto T, Iida A, Yamamoto H, Fujisaki N, Aokage T, Tsukahara K, Yamada T, Mandai Y, Osako T, Nakao A.

Case Rep Emerg Med. 2019 Jun 18;2019:4383086. doi: 10.1155/2019/4383086. eCollection 2019.

4.

Preparation of hybrid porcine thymus containing non-human primate thymic epithelial cells in miniature swine.

Sekijima M, Sahara H, Shimizu A, Iwanaga T, Murokawa T, Ariyoshi Y, Pomposelli T, Khosravi Maharlooei M, Sykes M, Yamada K.

Xenotransplantation. 2019 Nov;26(6):e12543. doi: 10.1111/xen.12543. Epub 2019 Jul 10.

PMID:
31293016
5.

Case of Nontraumatic Rectus Sheath Hematoma from Muscle Training Mimicking Acute Abdomen.

Ariyoshi Y, Naito H, Ihoriya H, Yumoto T, Fujisaki N, Tsukahara K, Yamada T, Mandai Y, Osako T, Nakao A.

Case Rep Emerg Med. 2019 May 23;2019:3158969. doi: 10.1155/2019/3158969. eCollection 2019.

6.

Needlescopic surgery for broad ligament hernia: A case report.

Koizumi N, Ariyoshi Y, Fujiki H, Sakakura C.

Asian J Endosc Surg. 2019 Feb 14. doi: 10.1111/ases.12692. [Epub ahead of print]

PMID:
30767408
7.

[A Case of Esophageal Gastrointestinal Stromal Tumor Resected by Mediastinoscope-Assisted Transhiatal Esophagectomy].

Ariyoshi Y, Koizumi N, Yasuoka R, Nakamura K, Fujiki H, Shiozaki A, Fujiwara H, Sakakura C.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2267-2269. Japanese.

PMID:
30692353
8.

A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K.

J Hum Genet. 2018 Dec;63(12):1259-1267. doi: 10.1038/s10038-018-0518-8. Epub 2018 Sep 28.

PMID:
30266950
9.

Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.

Shiozaki A, Ariyoshi Y, Iitaka D, Kosuga T, Shimizu H, Kudou M, Konishi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Ichikawa D, Otsuji E.

Gastric Cancer. 2019 May;22(3):473-485. doi: 10.1007/s10120-018-0874-2. Epub 2018 Sep 6.

PMID:
30191346
10.

Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.

Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K.

Transpl Int. 2018 Oct;31(10):1164-1177. doi: 10.1111/tri.13273. Epub 2018 Jun 5.

11.

Hydrogen sulfide prevents renal ischemia-reperfusion injury in CLAWN miniature swine.

Sekijima M, Sahara H, Miki K, Villani V, Ariyoshi Y, Iwanaga T, Tomita Y, Yamada K.

J Surg Res. 2017 Nov;219:165-172. doi: 10.1016/j.jss.2017.05.123. Epub 2017 Jun 28.

PMID:
29078877
12.

Effects of carbon monoxide on early dysfunction and microangiopathy following GalT-KO porcine pulmonary xenotransplantation in cynomolgus monkeys.

Sahara H, Sekijima M, Ariyoshi Y, Kawai A, Miura K, Waki S, Nathan L, Tomita Y, Iwanaga T, Nakano K, Matsunari H, Date H, Nagashima H, Shimizu A, Yamada K.

Xenotransplantation. 2018 Jan;25(1). doi: 10.1111/xen.12359. Epub 2017 Oct 25.

PMID:
29067747
13.

Ureterolithotripsy for a Ureteral Calculus at the Ureteroureterostomy of a Renal-transplant Recipient.

Mitsui Y, Wada K, Araki M, Yoshioka T, Ariyoshi Y, Nishimura S, Kobayashi Y, Sasaki K, Watanabe T, Nasu Y.

Acta Med Okayama. 2017 Oct;71(5):449-452. doi: 10.18926/AMO/55445.

14.

Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.

Horikawa Y, Watanabe M, Sadahira T, Ariyoshi Y, Kobayashi Y, Araki M, Wada K, Ochiai K, Li SA, Nasu Y.

Oncol Lett. 2017 Sep;14(3):3223-3228. doi: 10.3892/ol.2017.6548. Epub 2017 Jul 8.

15.

Robotic Renal Autotransplantation: First Case Outside of North America.

Araki M, Wada K, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Yoshioka T, Ariyoshi Y, Fujio K, Takamoto A, Sugimoto M, Sasaki K, Kobayashi Y, Ebara S, Taninishi H, Amano H, Inui M, Watanabe M, Watanabe T, Nasu Y.

Acta Med Okayama. 2017 Aug;71(4):351-355. doi: 10.18926/AMO/55313.

16.

The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy.

Mitsui Y, Sadahira T, Araki M, Wada K, Tanimoto R, Ariyoshi Y, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.

Clin Exp Nephrol. 2018 Apr;22(2):453-458. doi: 10.1007/s10157-017-1454-1. Epub 2017 Jul 24.

PMID:
28741049
17.

The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.

Mori A, Watanabe M, Sadahira T, Kobayashi Y, Ariyoshi Y, Ueki H, Wada K, Ochiai K, Li SA, Nasu Y.

Acta Med Okayama. 2017 Apr;71(2):135-142. doi: 10.18926/AMO/54982.

18.

Evaluation of Urinary Stone Composition and Differentiation between Urinary Stones and Phleboliths Using Single-source Dual-energy Computed Tomography.

Ogawa N, Sato S, Ida K, Kato K, Ariyoshi Y, Wada K, Nasu Y, Kanazawa S.

Acta Med Okayama. 2017 Apr;71(2):91-96. doi: 10.18926/AMO/54976.

19.

Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.

Sadahira T, Wada K, Ikawa K, Morikawa N, Kurahashi H, Yoshioka T, Ariyoshi Y, Kobayashi Y, Araki M, Ishii A, Watanabe M, Uehara S, Watanabe T, Nasu Y.

J Infect Chemother. 2017 Apr;23(4):214-217. doi: 10.1016/j.jiac.2016.12.010. Epub 2017 Jan 11.

PMID:
28089362
20.

Successful microscopic renal autotransplantation for left renal aneurysm associated with segmental arterial mediolysis.

Yoshioka T, Araki M, Ariyoshi Y, Wada K, Tanaka N, Nasu Y.

J Vasc Surg. 2017 Jul;66(1):261-264. doi: 10.1016/j.jvs.2016.09.039. Epub 2016 Dec 14.

21.

Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.

Ariyoshi Y, Shiozaki A, Ichikawa D, Shimizu H, Kosuga T, Konishi H, Komatsu S, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E.

Oncotarget. 2017 Jan 10;8(2):2209-2223. doi: 10.18632/oncotarget.13645.

22.

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.

Kumon H, Ariyoshi Y, Sasaki K, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Cancer Gene Ther. 2016 Nov;23(11):400-409. doi: 10.1038/cgt.2016.53. Epub 2016 Oct 21.

23.

The Efficacy of Rituximab in High-risk Renal Transplant Recipients.

Araki M, Wada K, Mitsui Y, Kubota R, Yoshioka T, Ariyoshi Y, Kobayashi Y, Kitagawa M, Tanabe K, Sugiyama H, Wada J, Watanabe M, Watanabe T, Hotta K, Nasu Y.

Acta Med Okayama. 2016 Aug;70(4):295-7.

24.

The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.

Ariyoshi Y, Watanabe M, Eikawa S, Yamazaki C, Sadahira T, Hirata T, Araki M, Ebara S, Nasu Y, Udono H, Kumon H.

Gene Ther. 2016 May;23(5):408-14. doi: 10.1038/gt.2016.7. Epub 2016 Feb 2.

PMID:
26836118
25.

Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.

Ochiai K, Morimatsu M, Kato Y, Ishiguro-Oonuma T, Udagawa C, Rungsuriyawiboon O, Azakami D, Michishita M, Ariyoshi Y, Ueki H, Nasu Y, Kumon H, Watanabe M, Omi T.

Oncotarget. 2016 Jan 19;7(3):3283-96. doi: 10.18632/oncotarget.6488.

26.

Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Clin Transl Sci. 2015 Dec;8(6):837-40. doi: 10.1111/cts.12362. Epub 2015 Dec 1.

27.

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Ebara S, Hiraki T, Kanazawa S, Yanai H, Watanabe M, Nasu Y.

Clin Med Insights Oncol. 2015 Mar 23;9:31-8. doi: 10.4137/CMO.S23252. eCollection 2015.

28.

[A case of mediastinal recurrence of esophageal cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration].

Ariyoshi Y, Shiozaki A, Fujiwara H, Konishi H, Morimura R, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Ichikawa D, Okamoto K, Sakakura C, Iwasaki Y, Otsuji E.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2372-4. Japanese.

PMID:
25731527
29.

A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.

Watanabe M, Sakaguchi M, Kinoshita R, Kaku H, Ariyoshi Y, Ueki H, Tanimoto R, Ebara S, Ochiai K, Futami J, Li SA, Huang P, Nasu Y, Huh NH, Kumon H.

Oncol Rep. 2014 Mar;31(3):1089-95. doi: 10.3892/or.2013.2958. Epub 2013 Dec 31.

30.

[Minimally invasive surgery for cancer arising in a reconstructed gastric tube after esophagectomy based on evaluation of blood and lymphatic flow by indocyanine green fluorescence imaging].

Ariyoshi Y, Fujiwara H, Shiozaki A, Konishi H, Komatsu S, Kubota T, Ichikawa D, Okamoto K, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Kimura A, Sakakura C, Otsuji E.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2170-2. Japanese.

PMID:
24394049
31.

Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder.

Kurahashi H, Watanabe M, Sugimoto M, Ariyoshi Y, Mahmood S, Araki M, Ishii K, Nasu Y, Nagai A, Kumon H.

Endocr J. 2013;60(12):1321-7. Epub 2013 Sep 18.

32.

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.

Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, Kimura Y, Ariyoshi Y, Haginomori S, Sakurai Y, Kinashi Y, Masunaga S, Fukushima M, Ono K, Maruhashi A.

J Radiat Res. 2014 Jan 1;55(1):146-53. doi: 10.1093/jrr/rrt098. Epub 2013 Aug 16.

33.

[Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].

Nakashima S, Fujita Y, Matsuo H, Ariyoshi Y, Fukuda K, Fujiyama J, Masuyama M.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1932-4. Japanese.

PMID:
23267934
34.

[Bisphosphonate-related osteonecrosis of the jaws].

Ariyoshi Y, Ueno T, Shimahara M.

Nihon Rinsho. 2012 Aug;70 Suppl 6:745-8. Japanese. No abstract available.

PMID:
23156608
35.

Carcinoma ex pleomorphic adenoma of the sublingual gland: a case report.

Ariyoshi Y, Shimahara M, Konda T, Tsuji M.

Int J Oral Sci. 2012 Mar;4(1):50-3. doi: 10.1038/ijos.2012.3. Epub 2012 Jan 12.

36.

Post-marketing surveillance (PMS) of all patients treated with irinotecan in Japan: clinical experience and ADR profile of 13,935 patients.

Tadokoro J, Kakihata K, Shimazaki M, Shiozawa T, Masatani S, Yamaguchi F, Sakata Y, Ariyoshi Y, Fukuoka M.

Jpn J Clin Oncol. 2011 Sep;41(9):1101-11. doi: 10.1093/jjco/hyr105. Epub 2011 Aug 17.

PMID:
21852251
37.
38.

A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.

Kubota K, Sakai H, Yamamoto N, Kunitoh H, Nakagawa K, Takeda K, Ichinose Y, Saijo N, Ariyoshi Y, Fukuoka M.

J Thorac Oncol. 2010 May;5(5):702-6. doi: 10.1097/JTO.0b013e3181ce3e22.

39.

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors.

Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, Hasegawa Y, Terashima M, Ueda S, Fukuoka M, Ariyoshi Y, Saito T, Masuda N, Watanabe H, Taguchi T, Kakihara T, Aoyama Y, Hashimoto Y, Nakagawa K.

Clin Cancer Res. 2009 Jun 1;15(11):3872-80. doi: 10.1158/1078-0432.CCR-08-1946. Epub 2009 May 26.

40.

[Pharmacological properties and clinical efficacy of the long-active angiotensin receptor blocker (ARB) irbesartan].

Ariyoshi Y, Mizumoto K.

Nihon Yakurigaku Zasshi. 2009 May;133(5):275-80. Review. Japanese. No abstract available.

PMID:
19443965
41.

Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.

Kimura Y, Ariyoshi Y, Shimahara M, Miyatake S, Kawabata S, Ono K, Suzuki M, Maruhashi A.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S47-9. doi: 10.1016/j.apradiso.2009.03.019. Epub 2009 Mar 26.

PMID:
19395269
42.

Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.

Ito Y, Kimura Y, Shimahara T, Ariyoshi Y, Shimahara M, Miyatake S, Kawabata S, Kasaoka S, Ono K.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S109-10. doi: 10.1016/j.apradiso.2009.03.018. Epub 2009 Mar 26.

PMID:
19395268
43.

Boron neutron capture therapy for papillary cystadenocarcinoma in the upper lip: a case report.

Kimura Y, Ariyoshi Y, Miyatake S, Shimahara M, Kawabata S, Ono K.

Int J Oral Maxillofac Surg. 2009 Mar;38(3):293-5. doi: 10.1016/j.ijom.2008.12.010.

PMID:
19179044
44.

Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002.

Ariyoshi Y, Shimahara M, Omura K, Yamamoto E, Mizuki H, Chiba H, Imai Y, Fujita S, Shinohara M, Seto K; Japanese Society of Oral and Maxillofacial Surgeons, 2002.

Int J Clin Oncol. 2008 Jun;13(3):220-8. doi: 10.1007/s10147-007-0756-9. Epub 2008 Jun 14.

PMID:
18553231
45.

Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.

Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M.

Oncol Rep. 2007 Oct;18(4):861-6.

PMID:
17786347
46.

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.

Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, Takada M, Fukuoka M, Ariyoshi Y, Fukuda H, Saijo N.

Lung Cancer. 2007 Dec;58(3):362-8. Epub 2007 Aug 22.

PMID:
17716779
47.

Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).

Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):786-92. Epub 2007 May 23.

PMID:
17512126
48.

Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies.

Tsunekawa S, Yamamoto N, Tsukamoto K, Itoh Y, Kaneko Y, Kimura T, Ariyoshi Y, Miura Y, Oiso Y, Niki I.

J Endocrinol. 2007 Apr;193(1):65-74.

PMID:
17400804
49.

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M.

Ann Oncol. 2007 Feb;18(2):317-23. Epub 2006 Nov 1.

PMID:
17079694
50.

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.

Yana T, Negoro S, Takada M, Yokota S, Takada Y, Sugiura T, Yamamoto H, Sawa T, Kawahara M, Katakami N, Ariyoshi Y, Fukuoka M; West Japan Thoracic Oncology Group.

Invest New Drugs. 2007 Jun;25(3):253-8. Epub 2006 Oct 13.

PMID:
17039404

Supplemental Content

Loading ...
Support Center